Total Payments
$3,173
2024 Payments
$1,464
Companies
30
Transactions
156
Medicare Patients
206
Medicare Billing
$29,542

Payment Breakdown by Category

Food & Beverage$3,173 (100.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $3,173 156 100.0%

Top Paying Companies

Company Total Records Latest Year
Bayer Healthcare Pharmaceuticals Inc. $448.79 22 $0 (2024)
Novo Nordisk Inc $426.20 22 $0 (2024)
Lilly USA, LLC $339.60 18 $0 (2024)
ABBVIE INC. $279.41 17 $0 (2024)
Amgen Inc. $239.92 8 $0 (2024)
PFIZER INC. $160.03 8 $0 (2024)
SANOFI-AVENTIS U.S. LLC $138.16 8 $0 (2024)
Amneal Pharmaceuticals LLC $135.55 8 $0 (2024)
E.R. Squibb & Sons, L.L.C. $124.93 1 $0 (2023)
Insulet Corporation $105.31 5 $0 (2024)

Payment History by Year

Year Amount Transactions Top Company
2024 $1,464 72 Novo Nordisk Inc ($327.11)
2023 $1,490 72 Bayer Healthcare Pharmaceuticals Inc. ($322.52)
2022 $219.21 12 Bayer HealthCare Pharmaceuticals Inc. ($94.31)

All Payment Transactions

156 individual payment records from CMS Open Payments — Page 7 of 7

Date Company Product Nature Form Amount Type
11/12/2022 Becton, Dickinson and Company BD Nano 2nd Gen Pen Needle (Device) Food and Beverage In-kind items and services $20.01 General
Category: Diabetes Care
11/07/2022 Bayer HealthCare Pharmaceuticals Inc. Kerendia (Drug) Food and Beverage In-kind items and services $21.08 General
Category: Cardio-renal
10/10/2022 Bayer HealthCare Pharmaceuticals Inc. Kerendia (Drug) Food and Beverage In-kind items and services $17.17 General
Category: Cardio-renal
09/27/2022 Ipsen Biopharmaceuticals, Inc SOMATULINE DEPOT (Drug) Food and Beverage In-kind items and services $18.04 General
Category: Oncology/Endocrinology
09/23/2022 Merck Sharp & Dohme LLC STEGLATRO (Drug) Food and Beverage In-kind items and services $13.87 General
Category: ENDOCRINOLOGY
08/23/2022 Bayer HealthCare Pharmaceuticals Inc. Kerendia (Drug) Food and Beverage In-kind items and services $18.47 General
Category: Cardio-renal

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 3 158 192 $80,271 $22,751
2022 2 48 48 $24,208 $6,791
Total Patients
206
Total Services
240
Medicare Billing
$29,542
Procedure Codes
7

All Medicare Procedures & Services

7 procedure records from CMS Medicare Utilization

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 35 64 $20,096 $7,226 36.0%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2023 46 46 $22,402 $6,728 30.0%
99222 Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes Facility 2023 46 46 $23,874 $5,451 22.8%
99204 New patient office or other outpatient visit, 45-59 minutes Facility 2023 15 15 $7,305 $1,719 23.5%
99214 Established patient office or other outpatient visit, 30-39 minutes Facility 2023 16 21 $6,594 $1,626 24.7%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2022 22 22 $10,714 $3,514 32.8%
99222 Initial hospital inpatient care per day, typically 50 minutes Facility 2022 26 26 $13,494 $3,277 24.3%

About Aakash Rajwani

Aakash Rajwani is a Student in an Organized Health Care Education/Training Program healthcare provider based in Staten Island, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/12/2018. The National Provider Identifier (NPI) number assigned to this provider is 1003392192.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Aakash Rajwani has received a total of $3,173 in payments from pharmaceutical and medical device companies, with $1,464 received in 2024. These payments were reported across 156 transactions from 30 companies. The most common payment nature is "Food and Beverage" ($3,173).

As a Medicare-enrolled provider, Rajwani has provided services to 206 Medicare beneficiaries, totaling 240 services with total Medicare billing of $29,542. Data is available for 2 years (2022–2023), covering 7 distinct procedure/service records.

Practice Information

Products in Payments

  • Kerendia (Drug) $448.79
  • Ozempic (Drug) $240.18
  • SYNTHROID (Drug) $202.57
  • EVENITY (Biological) $170.40
  • SOMAVERT (Drug) $160.03
  • MOUNJARO (Drug) $155.17
  • Rybelsus (Drug) $144.13
  • TZIELD (Biological) $138.16
  • UNITHROID (Drug) $135.55
  • JARDIANCE (Drug) $125.49
  • ELIQUIS (Drug) $124.93
  • Omnipod (Device) $105.31
  • MYCAPSSA (Drug) $74.61
  • TEPEZZA (Biological) $69.52
  • FARXIGA (Drug) $67.93
  • AFREZZA (Drug) $60.78
  • Tymlos (Drug) $59.64
  • JATENZO (Drug) $51.92
  • LICART (Drug) $50.93
  • BD Nano 2nd Gen Pen Needle (Device) $43.53

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Student in an Organized Health Care Education/Training Program Doctors in Staten Island